pI: 7.3803 |
Length (AA): 738 |
MW (Da): 84799 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
9 | 448 | 5wwr (A) | 102 | 465 | 24.00 | 0 | 0.97 | 0.572006 | 0.95 |
17 | 449 | 1ixk (A) | 13 | 315 | 31.00 | 0 | 1 | 0.471521 | 0.39 |
142 | 346 | 3m6u (A) | 86 | 247 | 39.00 | 0.0000065 | 1 | 0.328178 | 0.21 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127434)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G22400 | S-adenosyl-L-methionine-dependent methyltransferases superfamily protein |
Arabidopsis thaliana | AT4G40000 | S-adenosyl-L-methionine-dependent methyltransferases superfamily protein |
Babesia bovis | BBOV_IV000560 | proliferating-cell nucleolar protein, putative |
Brugia malayi | Bm1_48945 | Helicase conserved C-terminal domain containing protein |
Candida albicans | CaO19.518 | nuclear protein 1 |
Candida albicans | CaO19.8149 | nuclear protein 1 |
Caenorhabditis elegans | CELE_Y48G8AL.5 | Protein Y48G8AL.5 |
Cryptosporidium hominis | Chro.50016 | FLJ20303 protein |
Cryptosporidium parvum | cgd5_3560 | CNcl1p/MJ0026/YebU-like. SUN family methylase |
Dictyostelium discoideum | DDB_G0295715 | NOL1/NOP2/Sun family protein |
Drosophila melanogaster | Dmel_CG6133 | NOP2-Sun domain family, member 2 ortholog |
Echinococcus granulosus | EgrG_000210000 | tRNA cytosine34 C5 methyltransferase |
Entamoeba histolytica | EHI_103830 | tRNA (cytosine-5-)-methyltransferase, putative |
Entamoeba histolytica | EHI_098500 | tRNA (cytosine-5-)-methyltransferase, putative |
Echinococcus multilocularis | EmuJ_000210000 | tRNA (cytosine(34) C(5)) methyltransferase |
Giardia lamblia | GL50803_17199 | Sun/nucleolar protein family protein |
Homo sapiens | ENSG00000037474 | NOP2/Sun RNA methyltransferase family, member 2 |
Leishmania braziliensis | LbrM.35.2410 | hypothetical protein, conserved |
Leishmania braziliensis | LbrM.29.2510 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_292650.1 | NOL1/NOP2/sun family, putative |
Leishmania donovani | LdBPK_362300.1 | NOL1/NOP2/sun family, putative |
Leishmania infantum | LinJ.36.2300 | hypothetical protein, conserved |
Leishmania infantum | LinJ.29.2650 | hypothetical protein, conserved |
Leishmania major | LmjF.29.2540 | hypothetical protein, conserved |
Leishmania major | LmjF.36.2170 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.2170 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.08_29.2540 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_15436 | hypothetical protein |
Loa Loa (eye worm) | LOAG_03250 | hypothetical protein |
Loa Loa (eye worm) | LOAG_10108 | hypothetical protein |
Loa Loa (eye worm) | LOAG_10109 | hypothetical protein |
Mus musculus | ENSMUSG00000021595 | NOL1/NOP2/Sun domain family member 2 |
Neospora caninum | NCLIV_028690 | Multisite-specific tRNA m(5)C methyltransferase (EC 2.1.1.-), related |
Neospora caninum | NCLIV_001440 | NOL1/NOP2/sun family methyltransferase, related |
Oryza sativa | 4345871 | Os08g0484400 |
Oryza sativa | 4347343 | Os09g0471900 |
Onchocerca volvulus | OVOC13429 |
|
Plasmodium berghei | PBANKA_0801900 | methyltransferase, putative |
Plasmodium falciparum | PF3D7_0704200 | tRNA m5C-methyltransferase, putative |
Plasmodium knowlesi | PKNH_0102400 | NOL1/NOP2/sun family methyltransferase |
Plasmodium vivax | PVX_087750 | hypothetical protein, conserved |
Plasmodium yoelii | PY01948 | similar to yeast ncl1-related |
Saccharomyces cerevisiae | YBL024W | Ncl1p |
Schistosoma japonicum | Sjp_0050480 | ko:K00558 DNA (cytosine-5-)-methyltransferase [EC2.1.1.37], putative |
Schistosoma mansoni | Smp_175950 | methyltransferase ncl1 |
Trypanosoma brucei gambiense | Tbg972.10.8190 | hypothetical protein, conserved,member of the NOL1/NOP2/sun family of proteins |
Trypanosoma brucei gambiense | Tbg972.3.3390 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.3.3230 | NOL1/NOP2/sun family, putative |
Trypanosoma brucei | Tb927.10.6680 | member of the NOL1/NOP2/sun family of proteins |
Trypanosoma congolense | TcIL3000_3_2120 | NOL1/NOP2/sun family, putative |
Trypanosoma congolense | TcIL3000_10_5740 | member of the NOL1/NOP2/sun family of proteins |
Trypanosoma cruzi | TcCLB.510321.20 | NOL1/NOP2/sun family, putative |
Trypanosoma cruzi | TcCLB.510187.240 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.508153.370 | NOL1/NOP2/sun family, putative |
Trypanosoma cruzi | TcCLB.506699.3 | NOL1/NOP2/sun family, putative |
Toxoplasma gondii | TGME49_294440 | NOL1/NOP2/sun family protein |
Toxoplasma gondii | TGME49_255250 | tRNA (cytosine(34)-C(5))-methyltransferase, putative |
Theileria parva | TP01_0076 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_079770 | tRNA and rRNA cytosine-C5-methylase, putative |
Trichomonas vaginalis | TVAG_380890 | ribosomal RNA small subunit methyltransferase B, putative |
Trichomonas vaginalis | TVAG_427320 | ribosomal RNA small subunit methyltransferase B, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.6680 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.6680 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.6680 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.6680 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.3.3230 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.3230 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.3230 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.3230 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_294440 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_255250 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_294440 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_255250 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.